Latest Advances

  • Condition: Adult-onset Primary Hemophagocytic Lymphohistiocytosis
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: Haploidentical Hematopoietic Stem Cell Transplantation
  • Number of Patients: 15
  • Published —
The study researched the outcomes of haploidentical hematopoietic stem cell transplantation for adults with primary hemophagocytic lymphohistiocytosis.
  • Condition: Acquired tumor-associated and primary pure red cell aplasia
  • Journal: Annals of hematology
  • Treatment Used: Immunosuppression therapy
  • Number of Patients: 12
  • Published —
The study researched the safety and effectiveness of immunosuppression therapy in patients with acquired tumor-associated and primary pure red cell aplasia.
  • Condition: Lymphoproliferative Neoplasms
  • Journal: Critical reviews in oncology/hematology
  • Treatment Used: Fertility Preservation
  • Number of Patients: 0
  • Published —
This article reviews the gonadotoxic potential of classical chemotherapeutic treatments and novel targeted therapies for lymphoproliferative neoplasms in young patients to preserve and restore fertility after cancer healing.
  • Condition: Atypical Lymphoid Hyperplasia in Patient with Severe Obstructive Sleep Apnea
  • Journal: International journal of pediatric otorhinolaryngology
  • Treatment Used: Tonsillectomy
  • Number of Patients: 1
  • Published —
This case report describes a 17 year-old female with severe sleep apnea undergoing tonsillectomy who was diagnosed with atypical lymphoid hyperplasia.
  • Condition: Epstein-Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System
  • Journal: Viruses
  • Treatment Used: Chemo-immunotherapy
  • Number of Patients: 1
  • Published —
This case report describes a patient with Epstein-Barr virus-induced post-transplant lymphoproliferative disorder of the central nervous system that was treated using chemo-immunotherapy.
  • Condition: Epstein-Barr Virus-Associated Lymphoproliferative Disorder
  • Journal: Cancer science
  • Treatment Used: Alsterpaullone
  • Number of Patients: 0
  • Published —
This study tested the safety and efficacy of using alsterpaullone to treat patients with Epstein-Barr virus-associated lymphoproliferative disorders.
  • Condition: Immune Thrombocytopenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
  • Journal: Blood
  • Treatment Used: Eltrombopag
  • Number of Patients: 18
  • Published —
This study aimed to assess the safety and effectiveness of eltrombopag in patients with immune thrombocytopenia (ITP) secondary to chronic lymphoproliferative disorders (LPDs).
  • Condition: Deficiency of Adenosine Deaminase 2 (DADA2) in Pediatric Patient with Chronic Lymphoproliferation and Cytopenia
  • Journal: Pediatric hematology and oncology
  • Treatment Used: Etanercept, Monthly Intravenous Immunoglobulin, and Low-Dose Methylprednisolone
  • Number of Patients: 1
  • Published —
This case report describes a pediatric patient diagnosed with deficiency of adenosine deaminase 2 (DADA2) treated with etanercept, monthly intravenous immunoglobulin replacement, and low-dose methylprednisolone.
  • Condition: Epstein-Barr Virus Associated CNS Lymphoproliferative Disorder after Long-Term Immunosuppression
  • Journal: Practical neurology
  • Treatment Used: Mycophenolate Mofetil
  • Number of Patients: 1
  • Published —
This article reviews the role of mycophenolate mofetil in Epstein-Barr virus (EBV)-driven lymphoproliferative disorders, and discuss checking EBV status in all patients starting immunosuppression and in older people already taking immunosuppression.
  • Condition: Castleman Disease of the Tonsil
  • Journal: Diagnostic pathology
  • Treatment Used: Local Removal
  • Number of Patients: 1
  • Published —
The study researched the outcomes of a patient with Castleman disease of the tonsil.
  • Condition: B-cell chronic lymphoproliferative disorders (B-CLPD) with TP53 abnormalities
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: high-dose methylprednisolone with Rituximab and fresh frozen plasma (HDMP+RTX+FFP)
  • Number of Patients: 6
  • Published —
This study assessed whether high-dose methylprednisolone with rituximab and fresh frozen plasma (HDMP+RTX+FFP) for up to six cycles in improving outcomes for patients with B-cell chronic lymphoproliferative disorders (B-CLPD) with TP53 abnormalities.
  • Condition: Primary Cutaneous CD30+ Lymphoproliferative Disorders
  • Journal: Blood
  • Treatment Used: Skin-Directed and Systemic Therapies Monotherapy or Combination
  • Number of Patients: 0
  • Published —
This article discusses the treatment of primary cutaneous CD30+ lymphoproliferative disorders with skin-directed and systemic therapies monotherapy or combination.
Showing 1-12 of 17